Wall Street Analysts Are Bullish on Top Healthcare Picks

view original post

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Prothena (PRTAResearch Report) and Blueprint Medicines (BPMCResearch Report) with bullish sentiments.

Prothena (PRTA)

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Prothena, with a price target of $85.00. The company’s shares closed last Thursday at $28.52, close to its 52-week low of $24.29.

According to TipRanks.com, Butler has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -4.3% and a 39.9% success rate. Butler covers the Healthcare sector, focusing on stocks such as Vigil Neuroscience Inc, ACADIA Pharmaceuticals, and Viridian Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Prothena with a $70.29 average price target.

See today’s best-performing stocks on TipRanks >>

Blueprint Medicines (BPMC)

JMP Securities analyst Reni Benjamin reiterated a Buy rating on Blueprint Medicines today and set a price target of $114.00. The company’s shares closed last Thursday at $87.57, close to its 52-week high of $94.00.

According to TipRanks.com, Benjamin ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -8.4% and a 34.3% success rate. Benjamin covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Iovance Biotherapeutics, and Allogene Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Blueprint Medicines with a $92.08 average price target, which is a 18.7% upside from current levels. In a report issued on February 5, Stifel Nicolaus also maintained a Buy rating on the stock with a $97.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PRTA: